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Abstract 
Alternative splicing is a process by which multiple protein isoforms are generated 
from a single coding region by altering the ways in which exons are joined together. This 
pathway is used by cellular systems to both increase proteomic diversity from a limited 
number of genes and to precisely control gene expression. Bioinformatics and 
comparative genomics approaches have provided significant sequence and functional 
insight into the regulatory sequences that occur within exonic regions of a transcript. In 
vitro and in vivo strategies have also been developed to screen for exonic splicing 
enhancers and silencers (ESEs and ESSs) from small, randomized libraries. Much less is 
known about intronic splicing enhancers and silencers (ISEs and ISSs), although recent 
bioinformatics approaches are beginning to shed some light on these regulatory 
sequences. A thorough understanding of both exonic and intronic regulators is necessary 
to enable the programming of alternative splicing patterns, which will provide a powerful 
tool for interrogating and manipulating cellular function. 
We developed a generalizable in vivo screening strategy for generating intronic 
splicing regulatory elements (ISREs). Our high-throughput approach employed a 
systematic screening strategy with extensive genome-wide bioinformatic analyses and 
experimental characterization which included a small-scale RNAi screen. Using this 
approach, we identified ISRE consensus motifs, characterized the splicing regulatory 
networks (SRNs) associated with these regulatory elements and generated a model for 
ISRE regulatory function. Highlighting the complexity of SRNs, we found that cis-acting 
intronic regulatory sequences function through combinatorial effects from multiple 
elements and trans-acting factors, and that the immediate transcript context has a 
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dominant effect on ISRE function. Overall, this screening strategy provides a general 
method for generating regulatory sequences of alternative splicing events, which provide 
powerful tools for gene expression control. 
We next extended from our studies on cellular screening strategies for generating 
splicing regulatory elements, to build novel platforms that support the construction of 
protein-responsive alternative splicing control elements. Protein-binding RNA aptamers 
were inserted into key intronic locations of an alternatively spliced transcript to enable 
the detection of intracellular protein concentrations and to translate detection events to 
the regulation of alternative splicing patterns and thus gene expression. We demonstrate 
that these RNA elements can serve as autonomous control devices by linking endogenous 
nuclear protein levels to gene expression events and external stimuli to complex cellular 
phenotypes. These synthetic alternative splicing regulators can be implemented 
combinatorially to regulate alternative splicing patterns in response to multiple inputs. In 
addition, we applied these synthetic regulators to the rewiring of endogenous signal 
transduction pathways and building of novel regulatory networks for user-defined 
phenotypes. Our work provides an early example of a novel class of RNA-based 
“intelligent” therapeutics by directing increased signaling through pathways associated 
with disease to the triggering of apoptosis. These programmable sensing-actuation 
molecules will be broadly applied in health and medicine towards the early diagnosis and 
treatment of disease.  
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